Načítá se...
Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
OBJECTIVE: The comparative crude death rates (CDR) among non-vitamin K antagonist oral anticoagulants (NOACs) are unknown. Further, whether NOACs improve survival when compared with warfarin is also unclear. We compared CDR co-reported for four NOACs combined or separately versus warfarin within the...
Uloženo v:
| Vydáno v: | Open Heart |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5515169/ https://ncbi.nlm.nih.gov/pubmed/28761683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2017-000629 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|